Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-06-09

FDA Approved: PREGABALIN — Supplemental Application (Dr.Reddys Laboratories Inc)

View source ↗

Summary

FDA approved a supplemental application for pregabalin from Dr. Reddy's Laboratories Inc., authorizing a generic version under the approved labeling. This actio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pregabalin (Pregabalin)

Snippet

SUPPL AP for PREGABALIN (PREGABALIN)